Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01615705 · ClinicalTrials.gov registry record
Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
A clinical trial, sponsored by Sir Mortimer B. Davis - Jewish General Hospital.
- Completed
- Registry status
- 803
- Enrollment target
NCT01615705 is a clinical trial that has completed, run by Sir Mortimer B. Davis - Jewish General Hospital. The registered enrollment target is 803 participants.
The verdict
NCT01615705 has completed, sponsored by Sir Mortimer B. Davis - Jewish General Hospital.
- COMPLETED
- Registry status
- 803 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether biomarkers of inflammation, genetic thrombophilia and coagulation activation influence Post-Thrombotic Syndrome development in patients with symptomatic proximal deep venous thrombosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 803 participants |
| Start Date | 2004-06 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01615705
The ClinicalTrials.gov registry entry for NCT01615705 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 803 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sir Mortimer B. Davis - Jewish General Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01615705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01615705 about?
NCT01615705 is a clinical study titled "Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial". The purpose of this study is to evaluate whether biomarkers of inflammation, genetic thrombophilia and coagulation activation influence Post-Thrombotic Syndrome development in patients with symptomatic proximal deep venous thrombosis.
What is the current status of trial NCT01615705?
This trial is currently completed. The enrollment target is 803 participants. The study started on 2004-06. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01615705?
This trial is sponsored by Sir Mortimer B. Davis - Jewish General Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.